Patients with high REDD1 expression had worse overall survival rate (P < 0.05) and disease free survival rate (P < 0.05) than patients with low REDD1 expression (Fig. 2c and d) in serous carcinomas group. Here, DDIT4 is linked to serous adenocarcinoma.